Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 01, 2011 09:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs to Present at 4th Annual LD MICRO Growth Conference

BUFFALO, NY--(Marketwire - Dec 1, 2011) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company is scheduled to present at the 4th Annual LD MICRO Growth Conference, December 7-8,...
November 01, 2011 09:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs to Host Quarterly Update Call on November 10

BUFFALO, NY--(Marketwire - Nov 1, 2011) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it will host a quarterly update conference call at 10:00 a.m. ET on November 10, 2011. ...
October 24, 2011 09:00 ET | Source: Cleveland BioLabs, Inc.

International Journal of Radiation Oncology, Biology and Physics Publishes Cleveland BioLabs Study of CBLB502 Protection From Radiation Dermatitis and Oral Mucositis in Head and Neck Cancer Model

BUFFALO, NY--(Marketwire - Oct 24, 2011) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced pre-publication of a study demonstrating CBLB502's ability to both protect from local radiation...
October 19, 2011 09:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Announces Opening of New IND for CBLB502 in Cancer Patients

BUFFALO, NY--(Marketwire - Oct 19, 2011) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that a new Investigational New Drug (IND) application for clinical testing of CBLB502 in a variety...
October 03, 2011 09:00 ET | Source: Cleveland BioLabs, Inc.

Journal of Immunology Publishes Study of Cleveland BioLabs' Drug CBLB502 in Acute Renal Ischemic Failure

BUFFALO, NY--(Marketwire - Oct 3, 2011) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that a study demonstrating CBLB502's ability to inhibit acute renal ischemic failure was published...
September 26, 2011 08:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs and RUSNANO Enter Into Agreement to Form New Joint Venture to Develop Innovative Compounds for Cancer and Infectious Disease

BUFFALO, NY--(Marketwire - Sep 26, 2011) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it has entered into an agreement with Open Joint Stock Company RUSNANO, a $10 billion Russian...
September 19, 2011 09:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs Subsidiary Incuron Receives $5 Million Grant From Russian Federation Government Initiative

BUFFALO, NY--(Marketwire - Sep 19, 2011) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) and Incuron, LLC today announced that Incuron has been awarded a $5 million grant through the Russian Federation...
September 06, 2011 09:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs to Present at Rodman & Renshaw 13th Annual Healthcare Conference

BUFFALO, NY--(Marketwire - Sep 6, 2011) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company is scheduled to present at the Rodman & Renshaw 13th Annual Healthcare...
August 10, 2011 14:05 ET | Source: Cleveland BioLabs, Inc.

Science Translational Medicine Publishes Breakthrough Finding From Cleveland BioLabs and Incuron on Identification of Target and Mechanism of Action of Novel Anticancer Agents Curaxins

BUFFALO, NY--(Marketwire - Aug 10, 2011) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) and Incuron, LLC today announced that Science Translational Medicine, a leading peer-reviewed research magazine...
August 09, 2011 09:00 ET | Source: Cleveland BioLabs, Inc.

Cleveland BioLabs to Present at 2011 Wedbush Life Sciences Management Access Conference

BUFFALO, NY--(Marketwire - Aug 9, 2011) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the Company is scheduled to present at the 2011 Wedbush Life Sciences Management Access...